@article{dccb3d98e76f40e2b170f538dd67e7dc,
title = "Authors{\textquoteright} reply: PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?",
keywords = "Glutamate Carboxypeptidase II, Humans, Male, Positron-Emission Tomography, Prostatic Neoplasms/diagnostic imaging, Radiopharmaceuticals",
author = "Ian Alberts and Seide, {Svenja Elizabeth} and Clemens Mingels and Bohn, {Karl Peter} and Kuangyu Shi and Zacho, {Helle D.} and Axel Rominger and Ali Afshar-Oromieh",
year = "2021",
month = jul,
doi = "10.1007/s00259-021-05376-2",
language = "English",
volume = "48",
pages = "2307–2308",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Physica-Verlag",
number = "8",
}